Free Trial

Aehr Test Systems (AEHR) Competitors

Aehr Test Systems logo
$11.32 -0.60 (-5.03%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$11.30 -0.02 (-0.14%)
As of 06/13/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AEHR vs. TXG, TRNS, EYPT, ALNT, CTKB, LAB, SENS, QSI, MASS, and QTRX

Should you be buying Aehr Test Systems stock or one of its competitors? The main competitors of Aehr Test Systems include 10x Genomics (TXG), Transcat (TRNS), EyePoint Pharmaceuticals (EYPT), Allient (ALNT), Cytek Biosciences (CTKB), Standard BioTools (LAB), Senseonics (SENS), Quantum-Si (QSI), 908 Devices (MASS), and Quanterix (QTRX). These companies are all part of the "measuring and control equipment" industry.

Aehr Test Systems vs. Its Competitors

10x Genomics (NASDAQ:TXG) and Aehr Test Systems (NASDAQ:AEHR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, community ranking, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

In the previous week, 10x Genomics had 6 more articles in the media than Aehr Test Systems. MarketBeat recorded 7 mentions for 10x Genomics and 1 mentions for Aehr Test Systems. Aehr Test Systems' average media sentiment score of 1.87 beat 10x Genomics' score of 0.52 indicating that Aehr Test Systems is being referred to more favorably in the news media.

Company Overall Sentiment
10x Genomics Positive
Aehr Test Systems Very Positive

Aehr Test Systems has lower revenue, but higher earnings than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Aehr Test Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
10x Genomics$624.66M2.05-$182.63M-$1.30-8.01
Aehr Test Systems$61.48M5.48$33.16M$0.7814.51

Aehr Test Systems received 66 more outperform votes than 10x Genomics when rated by MarketBeat users. Likewise, 57.89% of users gave Aehr Test Systems an outperform vote while only 50.00% of users gave 10x Genomics an outperform vote.

CompanyUnderperformOutperform
10x GenomicsOutperform Votes
66
50.00%
Underperform Votes
66
50.00%
Aehr Test SystemsOutperform Votes
132
57.89%
Underperform Votes
96
42.11%

84.7% of 10x Genomics shares are owned by institutional investors. Comparatively, 69.7% of Aehr Test Systems shares are owned by institutional investors. 9.4% of 10x Genomics shares are owned by insiders. Comparatively, 6.2% of Aehr Test Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Aehr Test Systems has a net margin of 43.41% compared to 10x Genomics' net margin of -29.90%. Aehr Test Systems' return on equity of 21.09% beat 10x Genomics' return on equity.

Company Net Margins Return on Equity Return on Assets
10x Genomics-29.90% -25.40% -19.69%
Aehr Test Systems 43.41%21.09%18.08%

10x Genomics has a beta of 1.99, meaning that its share price is 99% more volatile than the S&P 500. Comparatively, Aehr Test Systems has a beta of 2.24, meaning that its share price is 124% more volatile than the S&P 500.

10x Genomics currently has a consensus price target of $15.81, indicating a potential upside of 51.85%. Aehr Test Systems has a consensus price target of $25.00, indicating a potential upside of 120.85%. Given Aehr Test Systems' stronger consensus rating and higher probable upside, analysts plainly believe Aehr Test Systems is more favorable than 10x Genomics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
10x Genomics
1 Sell rating(s)
8 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.38
Aehr Test Systems
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Aehr Test Systems beats 10x Genomics on 13 of the 18 factors compared between the two stocks.

Get Aehr Test Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for AEHR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AEHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AEHR vs. The Competition

MetricAehr Test SystemsInstruments to measure electricity IndustryComputer SectorNASDAQ Exchange
Market Cap$337.01M$4.16B$26.20B$8.50B
Dividend YieldN/A0.45%2.85%4.17%
P/E Ratio15.0922.7544.5119.66
Price / Sales5.482.531,698.14152.07
Price / Cash9.5417.8734.7434.64
Price / Book2.933.356.824.59
Net Income$33.16M$135.28M$742.69M$248.23M
7 Day Performance-0.18%0.88%-0.43%-1.07%
1 Month Performance21.85%4.69%1.49%2.59%
1 Year Performance-14.31%-0.78%52,718.72%13.50%

Aehr Test Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AEHR
Aehr Test Systems
3.5914 of 5 stars
$11.32
-5.0%
$25.00
+120.8%
-14.3%$337.01M$61.48M15.0990Positive News
Gap Down
TXG
10x Genomics
4.2267 of 5 stars
$10.09
+7.1%
$15.81
+56.7%
-48.6%$1.24B$624.66M-6.641,240Positive News
Analyst Forecast
Gap Up
High Trading Volume
TRNS
Transcat
2.9399 of 5 stars
$76.68
-1.7%
$114.00
+48.7%
-34.9%$714.50M$278.42M41.45920
EYPT
EyePoint Pharmaceuticals
2.1889 of 5 stars
$8.93
-0.1%
$25.38
+184.2%
-3.7%$614.48M$56.04M-4.47120Positive News
Analyst Revision
Gap Up
ALNT
Allient
2.4975 of 5 stars
$33.36
+4.6%
$31.00
-7.1%
+39.2%$564.75M$516.06M37.911,950Positive News
CTKB
Cytek Biosciences
2.2785 of 5 stars
$3.56
+3.5%
$5.60
+57.3%
-42.7%$450.91M$197.05M-44.49500Positive News
High Trading Volume
LAB
Standard BioTools
2.6691 of 5 stars
$1.08
+1.9%
$2.50
+131.5%
-51.2%$410.21M$169.69M-1.52620Positive News
SENS
Senseonics
2.572 of 5 stars
$0.53
+0.6%
$1.55
+192.5%
+28.6%$346.73M$23.68M-4.0890Positive News
QSI
Quantum-Si
2.6444 of 5 stars
$1.71
-1.7%
$3.48
+103.2%
+21.2%$313.78M$3.44M-2.67150Positive News
MASS
908 Devices
1.754 of 5 stars
$6.98
+0.6%
$5.33
-23.6%
+25.8%$250.31M$63.99M-3.9460Positive News
Analyst Forecast
Gap Up
QTRX
Quanterix
3.3928 of 5 stars
$5.06
-5.8%
$15.60
+208.3%
-54.5%$196.48M$133.92M-4.77460News Coverage
Insider Trade
Gap Up

Related Companies and Tools


This page (NASDAQ:AEHR) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners